Evaluating the Therapeutic Potential of Different Sources of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome

Scientists investigated which sources of MSC: bone marrow derived-MSCs, adipose tissue derived-MSCs, and umbilical cord derived-MSCs would be the optimal candidate to be used as a therapy in an lipopolysaccharide-induced mouse model of acute respiratory distress syndrome.